黄干燥提取物的潜在系统性抗炎作用
Concetta Montanino1, Federica Farinella1, Bruna De Felice1
1Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania Luigi Vanvitelli, Caserta, 81100, Italy.
Endocrine, metabolic & immune disorders drug targets
|January 10, 2025
概括
这项研究比较了两个黄素配方的抗炎和降胆固醇作用. 与传统的脂溶性黄素相比,水溶性黄素显著减少了炎症标志物和LDL胆固醇.
科学领域:
- 药理学 药理学是指药理学的学科.
- 营养保健品 营养保健品
- 炎症研究 炎症研究
背景情况:
- 来自黄的黄素以其治疗潜力而闻名,但其生物可用性较差.
- 像皮佩林结合和脂/脂质体复合体等策略旨在增强黄素的吸收.
- 这项研究研究了两种不同的黄素配方:一种传统的脂溶性版本和一种创新的水溶性微粒形式 (Curcuin).
研究的目的:
- 为了比较一个标准的95%黄素配方与一种新型水溶性黄素 (Curcuin) 的全身抗炎作用.
- 评估这些配方对关键炎症和脂质生物标志物的影响.
主要方法:
- 一项涉及30名患者的研究分为两组.
- 第1组接受了425mg/天95%的黄素与皮佩林90天.
- 第二组每天接受100毫克标准化水溶性黄素 (Curcuin) 在微粒水溶液中.
主要成果:
- 这两种黄素配方都导致红细胞沉率 (ESR),C反应蛋白 (CRP),费里丁和LDL胆固醇水平降低.
- 库尔库林组在这些参数中显示出明显更大的减少,相比于95%的库尔库明与piperine组.
- 这些发现表明这两种配方的抗炎和降胆固醇作用.
结论:
- 两种测试的黄素提取物都有效地降低了炎症标志物和LDL胆固醇.
- 水溶性配方库尔库因表现出更明显的效果,表明其作为辅助疗法的潜力.
- 需要进一步的研究来优化黄素的剂量,形式和频率,以便在临床应用.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
01:29Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119